Compare BWMX & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWMX | OVID |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 622.7M | 562.5M |
| IPO Year | 2019 | 2017 |
| Metric | BWMX | OVID |
|---|---|---|
| Price | $15.45 | $2.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $27.83 | $4.60 |
| AVG Volume (30 Days) | 64.6K | ★ 1.5M |
| Earning Date | 04-23-2026 | 05-13-2026 |
| Dividend Yield | ★ 9.11% | N/A |
| EPS Growth | N/A | ★ 3.90 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,252,000.00 |
| Revenue This Year | $18.17 | N/A |
| Revenue Next Year | $25.68 | $19.34 |
| P/E Ratio | $12.54 | ★ N/A |
| Revenue Growth | N/A | ★ 1181.27 |
| 52 Week Low | $12.34 | $1.12 |
| 52 Week High | $19.79 | $3.11 |
| Indicator | BWMX | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 31.46 | 51.67 |
| Support Level | $13.50 | $2.38 |
| Resistance Level | $19.22 | $2.77 |
| Average True Range (ATR) | 0.49 | 0.14 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 16.39 | 32.26 |
Betterware de Mexico SAPI de CV is a company in the consumer product goods industry focused on home organization and beauty and personal care products, commercialized through person-to-person selling. The Group operates through two segments: Home organization under the Betterware brand, including kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, bedroom and wellness. Products are sold through catalogues and distributed through distributors and associates. The Beauty and personal care (B&PC) segment under the JAFRA brand, which generates maximum revenue, includes fragrance, color, skin care and toiletries, distributed through leaders and consultants. The Group operates in Mexico, which generates maximum revenue, the United States and Latam.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.